Home » Stocks » PHAR » Statistics

Pharming Group N.V. (PHAR)

Stock Price: $11.08 USD 0.13 (1.19%)
Updated Jun 23, 2021 4:00 PM EDT - Market closed

Total Valuation

Pharming Group has a market cap or net worth of $709.12 million. The enterprise value is $690.27 million.

Market Cap 709.12M
Enterprise Value 690.27M

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

Pharming Group has 64.00 million shares outstanding.

Shares Outstanding 64.00M
Share Change (YoY) n/a
Share Change (QoQ) -89.97%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float n/a

Valuation Ratios

The trailing PE ratio is 18.93.

PE Ratio 18.93
Forward PE n/a
PS Ratio 3.13
PB Ratio 3.89
P/FCF Ratio 8.32
PEG Ratio n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.34, with a EV/FCF ratio of 8.10.

EV / Earnings 17.13
EV / Sales 3.05
EV / EBITDA 12.34
EV / EBIT 14.67
EV / FCF 8.10

Financial Position

The company has a current ratio of 3.43, with a Debt / Equity ratio of 1.02.

Current Ratio 3.43
Quick Ratio 3.15
Debt / Equity 1.02
Debt / EBITDA 3.32
Debt / FCF 2.18

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Capital (ROIC) 29.40%
Revenue Per Employee $864,336
Profits Per Employee $153,766
Employee Count 262
Asset Turnover 0.65
Inventory Turnover n/a

Taxes

In the past 12 months, Pharming Group has paid $6.78 million in income taxes. This is 2.99% of the company's revenue.

Income Tax 6.78M
Effective Tax Rate 14.40%
Taxes as % of Revenue 2.99%

Stock Price Statistics

The stock price has decreased by -34.43% in the last 52 weeks.

Beta (1Y) n/a
52-Week Price Change -34.43%
50-Day Moving Average 12.19
200-Day Moving Average 13.42
Average Volume (30 Days) 3,580

Short Selling Information

The latest short interest is 7,913, so 0.01% of the outstanding shares have been sold short.

Short Interest 7,913
Short % of Shares Out 0.01%
Short Ratio (days to cover) 0.00

Income Statement

In the last 12 months, Pharming Group had revenue of $226.46 million and earned $40.29 million in profits. Earnings per share was $0.59.

Revenue 226.46M
Gross Profit 201.33M
Operating Income -42.46M
Pretax Income 47.06M
Net Income 40.29M
EBITDA 55.94M
EBIT 47.06M
Earnings Per Share (EPS) $0.59
Full Income Statement

Balance Sheet

The company has $204.73 million in cash and $185.88 million in debt, giving a net cash position of $18.85 million or $0.29 per share.

Cash & Cash Equivalents 204.73M
Total Debt 185.88M
Net Cash 18.85M
Net Cash Per Share $0.29
Book Value 182.17M
Book Value Per Share 2.85
Working Capital 185.08M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $90.20 million and capital expenditures -$4.97 million, giving a free cash flow of $85.23 million.

Operating Cash Flow 90.20M
Capital Expenditures -4.97M
Free Cash Flow 85.23M
FCF Per Share $1.33
Cash Flow Statement

Margins

Gross margin is 88.91%, with operating and profit margins of -18.75% and 17.79%.

Gross Margin 88.91%
Operating Margin -18.75%
Pretax Margin 20.78%
Profit Margin 17.79%
EBITDA Margin 24.70%
EBIT Margin 20.78%
FCF Margin 37.64%

Dividends & Yields

Pharming Group does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Earnings Yield 5.68%
FCF Yield 12.02%
Dividend Growth (YoY) n/a
Payout Ratio n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a